Images below confirm clinical responses seen in patients with metastatic orbital (eye), temporal (brain), liver, and spine ...

Around 100 participants with type 2 diabetes mellitus will be enrolled across US sites.

Panakeia publishes landmark clinical validation showing AI can deliver rapid molecular profiling for colorectal cancer ...

Swiss pharmaceutical giant Roche announced positive results from a Phase II trial of its obesity drug CT-388, which showed ...

Rifaximin SSD failed to significantly delay the onset of HE in patients with liver cirrhosis, but Bausch is yet to scrap the molecule’s development.

Bristol Myers Squibb BMY recently collaborated with clinical-stage biopharma company Janux Therapeutics to jointly develop a ...

Bial, an innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, today announced that 75% of patients currently enrolled in its ongoing Phase 2b clinical study ACTIVATE ...

Discusses 3-Year Topline Results From EMBARK Phase 3 Trial of ELEVIDYS in Duchenne Muscular Dystrophy January 26, ...

Intellia Therapeutics NTLA announced that the FDA lifted the clinical hold on the investigational new drug application (IND) ...

City of Hope has opened a phase 2 clinical trial comparing three different strategies for protecting heart health in prostate cancer patients who receive androgen deprivation therapy (ADT), ...

Shares of Bausch Health BHC were down 1.86% on Jan. 26. This was the second consecutive session when shares slid. BHC stock ...

Peer-reviewed Phase 2 Results Inform Ongoing Phase 3/Pivotal Trial of Celeste® in Parkinson’s Disease The Phase 2 study ...